• mail us help@statsmarketresearch.com
  • Int'l +1(332) 2424 294
  • Asia: (+91)-916-916-4321

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Colon Cancer Market - Global Outlook and Forecast 2022-2028

Colon Cancer Market - Global Outlook and Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 13 July 2022
  • Pages :64
  • Formats:
  • Report Code:SMR-7203340
OfferClick for best price

Best Price: $2600

Colon Cancer Market Size, Share 2022


Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation.

This report contains market size and forecasts of Colon Cancer in Global, including the following market information:

Global Colon Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Colon Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Colon Cancer include Bedford Laboratories, Sanofi Aventis, Bayer, GlaxoSmithKline and Teva Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Colon Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Colon Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Colon Cancer Market Segment Percentages, by Type, 2021 (%)

Surgery

Chemotherapy

Radiation

Global Colon Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Colon Cancer Market Segment Percentages, by Application, 2021 (%)

Hospitals

Ambulatory Surgical Centers

Others

Global Colon Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Colon Cancer Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Colon Cancer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Colon Cancer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bedford Laboratories

Sanofi Aventis

Bayer

GlaxoSmithKline

Teva Pharmaceutical Industries

Report Attributes Report Details
Report Title Colon Cancer Market - Global Outlook and Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 64 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Colon Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colon Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colon Cancer Overall Market Size
2.1 Global Colon Cancer Market Size: 2021 VS 2028
2.2 Global Colon Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colon Cancer Players in Global Market
3.2 Top Global Colon Cancer Companies Ranked by Revenue
3.3 Global Colon Cancer Revenue by Companies
3.4 Top 3 and Top 5 Colon Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Colon Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colon Cancer Players in Global Market
3.6.1 List of Global Tier 1 Colon Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Colon Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Colon Cancer Market Size Markets, 2021 & 2028
4.1.2 Surgery
4.1.3 Chemotherapy
4.1.4 Radiation
4.2 By Type - Global Colon Cancer Revenue & Forecasts
4.2.1 By Type - Global Colon Cancer Revenue, 2017-2022
4.2.2 By Type - Global Colon Cancer Revenue, 2023-2028
4.2.3 By Type - Global Colon Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colon Cancer Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Others
5.2 By Application - Global Colon Cancer Revenue & Forecasts
5.2.1 By Application - Global Colon Cancer Revenue, 2017-2022
5.2.2 By Application - Global Colon Cancer Revenue, 2023-2028
5.2.3 By Application - Global Colon Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Colon Cancer Market Size, 2021 & 2028
6.2 By Region - Global Colon Cancer Revenue & Forecasts
6.2.1 By Region - Global Colon Cancer Revenue, 2017-2022
6.2.2 By Region - Global Colon Cancer Revenue, 2023-2028
6.2.3 By Region - Global Colon Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Colon Cancer Revenue, 2017-2028
6.3.2 US Colon Cancer Market Size, 2017-2028
6.3.3 Canada Colon Cancer Market Size, 2017-2028
6.3.4 Mexico Colon Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Colon Cancer Revenue, 2017-2028
6.4.2 Germany Colon Cancer Market Size, 2017-2028
6.4.3 France Colon Cancer Market Size, 2017-2028
6.4.4 U.K. Colon Cancer Market Size, 2017-2028
6.4.5 Italy Colon Cancer Market Size, 2017-2028
6.4.6 Russia Colon Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Colon Cancer Market Size, 2017-2028
6.4.8 Benelux Colon Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Colon Cancer Revenue, 2017-2028
6.5.2 China Colon Cancer Market Size, 2017-2028
6.5.3 Japan Colon Cancer Market Size, 2017-2028
6.5.4 South Korea Colon Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Colon Cancer Market Size, 2017-2028
6.5.6 India Colon Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Colon Cancer Revenue, 2017-2028
6.6.2 Brazil Colon Cancer Market Size, 2017-2028
6.6.3 Argentina Colon Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colon Cancer Revenue, 2017-2028
6.7.2 Turkey Colon Cancer Market Size, 2017-2028
6.7.3 Israel Colon Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Colon Cancer Market Size, 2017-2028
6.7.5 UAE Colon Cancer Market Size, 2017-2028
7 Players Profiles
7.1 Bedford Laboratories
7.1.1 Bedford Laboratories Corporate Summary
7.1.2 Bedford Laboratories Business Overview
7.1.3 Bedford Laboratories Colon Cancer Major Product Offerings
7.1.4 Bedford Laboratories Colon Cancer Revenue in Global Market (2017-2022)
7.1.5 Bedford Laboratories Key News
7.2 Sanofi Aventis
7.2.1 Sanofi Aventis Corporate Summary
7.2.2 Sanofi Aventis Business Overview
7.2.3 Sanofi Aventis Colon Cancer Major Product Offerings
7.2.4 Sanofi Aventis Colon Cancer Revenue in Global Market (2017-2022)
7.2.5 Sanofi Aventis Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Colon Cancer Major Product Offerings
7.3.4 Bayer Colon Cancer Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Colon Cancer Major Product Offerings
7.4.4 GlaxoSmithKline Colon Cancer Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Corporate Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Colon Cancer Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Colon Cancer Revenue in Global Market (2017-2022)
7.5.5 Teva Pharmaceutical Industries Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Colon Cancer Market Opportunities & Trends in Global Market
Table 2. Colon Cancer Market Drivers in Global Market
Table 3. Colon Cancer Market Restraints in Global Market
Table 4. Key Players of Colon Cancer in Global Market
Table 5. Top Colon Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Colon Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Colon Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Colon Cancer Product Type
Table 9. List of Global Tier 1 Colon Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colon Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Colon Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Colon Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Colon Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Colon Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Colon Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Colon Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Colon Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Colon Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Colon Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Colon Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Colon Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Colon Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Colon Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Colon Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Colon Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Colon Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Colon Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Colon Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Colon Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Bedford Laboratories Corporate Summary
Table 31. Bedford Laboratories Colon Cancer Product Offerings
Table 32. Bedford Laboratories Colon Cancer Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Aventis Corporate Summary
Table 34. Sanofi Aventis Colon Cancer Product Offerings
Table 35. Sanofi Aventis Colon Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Colon Cancer Product Offerings
Table 38. Bayer Colon Cancer Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Colon Cancer Product Offerings
Table 41. GlaxoSmithKline Colon Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceutical Industries Corporate Summary
Table 43. Teva Pharmaceutical Industries Colon Cancer Product Offerings
Table 44. Teva Pharmaceutical Industries Colon Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Colon Cancer Segment by Type in 2021
Figure 2. Colon Cancer Segment by Application in 2021
Figure 3. Global Colon Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Colon Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Colon Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colon Cancer Revenue in 2021
Figure 8. By Type - Global Colon Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Colon Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Colon Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Colon Cancer Revenue Market Share, 2017-2028
Figure 12. US Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Colon Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Colon Cancer Revenue Market Share, 2017-2028
Figure 24. China Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Colon Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Colon Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Colon Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Bedford Laboratories Colon Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Aventis Colon Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Colon Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Colon Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceutical Industries Colon Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount